A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins
出版年份 2018 全文链接
标题
A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins
作者
关键词
-
出版物
JOURNAL OF VIROLOGY
Volume 92, Issue 12, Pages -
出版商
American Society for Microbiology
发表日期
2018-03-28
DOI
10.1128/jvi.02230-17
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Differences in Glycoprotein Complex Receptor Binding Site Accessibility Prompt Poor Cross-Reactivity of Neutralizing Antibodies between Closely Related Arenaviruses
- (2017) Rachel B. Brouillette et al. JOURNAL OF VIROLOGY
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- A Recombinant Vesicular Stomatitis Virus Ebola Vaccine
- (2017) Jason A. Regules et al. NEW ENGLAND JOURNAL OF MEDICINE
- Convergent immunological solutions to Argentine hemorrhagic fever virus neutralization
- (2017) Antra Zeltina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein
- (2017) Benson Y.H. Cheng et al. VIROLOGY
- Activity inhibition and crystal polymorphism induced by active-site metal swapping
- (2017) Elsie Yekwa et al. Acta Crystallographica Section D-Structural Biology
- Activation of the RLR/MAVS Signaling Pathway by the L Protein of Mopeia Virus
- (2016) Lei-Ke Zhang et al. JOURNAL OF VIROLOGY
- The High Degree of Sequence Plasticity of the Arenavirus Noncoding Intergenic Region (IGR) Enables the Use of a Nonviral Universal Synthetic IGR To Attenuate Arenaviruses
- (2016) Masaharu Iwasaki et al. JOURNAL OF VIROLOGY
- Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever
- (2016) Joseph W. Golden et al. JOURNAL OF VIROLOGY
- Monoclonal antibody therapy for Junin virus infection
- (2016) Larry Zeitlin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evidence of human infection by a new mammarenavirus endemic to Southeastern Asia
- (2016) Kim R Blasdell et al. eLife
- Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus
- (2015) Kristian G. Andersen et al. CELL
- Molecular Basis for Antibody-Mediated Neutralization of New World Hemorrhagic Fever Mammarenaviruses
- (2015) Selma Mahmutovic et al. Cell Host & Microbe
- Development of Live-Attenuated Arenavirus Vaccines Based on Codon Deoptimization
- (2015) Benson Yee Hin Cheng et al. JOURNAL OF VIROLOGY
- Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines
- (2015) Benson Yee Hin Cheng et al. JOURNAL OF VIROLOGY
- General Molecular Strategy for Development of Arenavirus Live-Attenuated Vaccines
- (2015) Masaharu Iwasaki et al. JOURNAL OF VIROLOGY
- The Glycoprotein Precursor Gene of Junin Virus Determines the Virulence of the Romero Strain and the Attenuation of the Candid #1 Strain in a Representative Animal Model of Argentine Hemorrhagic Fever
- (2015) Alexey V. Seregin et al. JOURNAL OF VIROLOGY
- Gairo virus, a novel arenavirus of the widespread Mastomys natalensis : Genetically divergent, but ecologically similar to Lassa and Morogoro viruses
- (2015) Sophie Gryseels et al. VIROLOGY
- A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
- (2015) David Safronetz et al. PLoS Neglected Tropical Diseases
- The Z Proteins of Pathogenic but Not Nonpathogenic Arenaviruses Inhibit RIG-i-Like Receptor-Dependent Interferon Production
- (2015) Junji Xing et al. JOURNAL OF VIROLOGY
- Exonuclease Domain of the Lassa Virus Nucleoprotein Is Critical To Avoid RIG-I Signaling and To Inhibit the Innate Immune Response
- (2014) S. Reynard et al. JOURNAL OF VIROLOGY
- Infection of Type I Interferon Receptor-Deficient Mice with Various Old World Arenaviruses: A Model for Studying Virulence and Host Species Barriers
- (2013) Toni Rieger et al. PLoS One
- An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity
- (2013) Juan C Zapata et al. Virology Journal
- Arenavirus Nucleoprotein Targets Interferon Regulatory Factor-Activating Kinase IKK
- (2012) C. Pythoud et al. JOURNAL OF VIROLOGY
- Characterization of virulence-associated determinants in the envelope glycoprotein of Pichinde virus
- (2012) Naveen Kumar et al. VIROLOGY
- The Major Determinant of Attenuation in Mice of the Candid1 Vaccine for Argentine Hemorrhagic Fever Is Located in the G2 Glycoprotein Transmembrane Domain
- (2011) C. G. Albarino et al. JOURNAL OF VIROLOGY
- Lassa Virus Nucleoprotein Mutants Generated by Reverse Genetics Induce a Robust Type I Interferon Response in Human Dendritic Cells and Macrophages
- (2011) X. Carnec et al. JOURNAL OF VIROLOGY
- Human Dendritic Cells Infected with the Nonpathogenic Mopeia Virus Induce Stronger T-Cell Responses than Those Infected with Lassa Virus
- (2011) D. Pannetier et al. JOURNAL OF VIROLOGY
- Induction and Inhibition of Type I Interferon Responses by Distinct Components of Lymphocytic Choriomeningitis Virus
- (2010) S. Zhou et al. JOURNAL OF VIROLOGY
- Cap binding and immune evasion revealed by Lassa nucleoprotein structure
- (2010) Xiaoxuan Qi et al. NATURE
- Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates
- (2008) Igor S. Lukashevich et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More